Moneycontrol PRO
Upcoming Event:Join us for the exciting discussion with Danone on role of nutrition, protein in working professionals’ quality of life on July 31, 3pm.

Buy Divis Laboratories: target of Rs 4810: Sharekhan

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4810 in its research report dated May 28, 2021.

June 10, 2021 / 11:37 AM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Divis Laboratories

Divis reported yet another impressive performance for Q4FY2021 with results ahead of estimates. Sales for Q4 were up 28.7% yoy while PAT grew 50.4%. Expanded capacities commissioning coupled with a robust growth outlook could open up substantial growth opportunities for the company. Divis has identified new growth avenues which include shortlisting of next set of 10 molecules and pursuing opportunities in contrast media manufacturing, which could be the key growth drivers.


We maintain our Buy recommendation on Divis Laboratories Limited (Divis) with a revised PT of Rs. 4,810.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: May 31, 2021 01:40 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark